Hemington Wealth Management’s GSK GSK Stock Holding History

Hemington Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$84K	Buy	1,955 +40	+2%	+$1.56K	0.01%	271
2025 Q2	$73K	Hold	1,915	–	–	0.01%	263
2025 Q1	$74K	Hold	1,915	–	–	0.01%	253
2024 Q4	$64K	Sell	1,915 -141	-7%	-$5.08K	0.02%	266
2024 Q3	$75K	Buy	+2,056	New	+$84.1K	0.02%	228
2022 Q3	–	Sell	-4,243	Closed	-$231K	–	95
2022 Q2	$231K	Hold	4,243	–	–	0.09%	93
2022 Q1	$231K	Buy	+4,243	New	+$230K	0.08%	99
2021 Q4	–	Sell	-4,243	Closed	-$203K	–	90
2021 Q3	$203K	Hold	4,243	–	–	0.07%	96
2021 Q2	$211K	Buy	+4,243	New	+$204K	0.09%	85

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hemington Wealth Management's GSK Position: Q3 2025 in Review

Hemington Wealth Management increased its GSK (GSK) stake by 2.1% in Q3 2025, buying an estimated $1.56K and bringing the position to 1,955 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #271.

Hemington Wealth Management first reported a position in GSK in Q2 2021 and has held it in 9 quarters since. The position peaked at $231K in Q2 2022. 895 funds tracked by Wall St. Rank hold GSK as of Q3 2025.

Hemington Wealth Management held 1,955 shares of GSK worth $84K as of Q3 2025.
Hemington Wealth Management bought 40 GSK shares in Q3 2025, an estimated $1.56K.
GSK made up 0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #271 holding.
Hemington Wealth Management first reported a position in GSK in Q2 2021 and has held it in 9 quarters since.
Hemington Wealth Management's GSK position peaked at $231K in Q2 2022.
895 funds tracked by Wall St. Rank held GSK as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.